UmeshJadhavChaudhariMD

Physician

Dr. Chaudhari is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 1996 - 1999
Rutgers Robert Wood Johnson Medical SchoolClass of 1996

PubMed

307 citations
Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ...
Christopher P. Cannon, Bertrand Cariou, Dirk J. Blom, James M. McKenney, Christelle Lorenzato
European Heart Journal. 2015-05-14
276 citations
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab among high cardiovascular risk patients on maximally tolerated statin the...
Dean J. Kereiakes, Jennifer G. Robinson, Christopher P. Cannon, Christelle Lorenzato, Robert Pordy
American Heart Journal. 2015-06-01
143 citations
Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab: Pooled Data From Randomized Trials
Jennifer G. Robinson, Robert S. Rosenson, Michel Farnier, Umesh Chaudhari, William J. Sasiela
Journal of the American College of Cardiology. 2017-02-07

Abstracts/Posters

Pozelimab, a Human Antibody Against Complement Factor C5, Demonstrates Robust Inhibition of Alternative Complement Activity Both in Normal Human Serum and in Phase I N...
Umesh Chaudhari, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Epidemiology of PNH and Real-World Treatment Patterns Following an Incident PNH Diagnosis in the US
Umesh Chaudhari, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019